La bourse est fermée

CAC 40
6 742,25
-11,72(-0,17 %)
Euro Stoxx 50
3 977,90
-6,60(-0,17 %)
Dow Jones
34 429,88
+34,87(+0,10 %)
EUR/USD
1,0531
+0,0002(+0,02 %)
Gold future
1 811,40
-3,80(-0,21 %)
BTC-EUR
16 102,50
-73,15(-0,45 %)

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Cours en temps réel. Devise en USD

Ajouter à la liste dynamique

150,46

-2,15

(-1,41 %)

À la clôture : 04:03PM EST

151,04

+0,58

(+0,39 %)

Échanges après Bourse :

05:14PM EST

Les cours des transactions proviennent de certains marchés

Cap. boursière	17,135B
Bêta (mensuel sur 5 ans)	1,01
Rapport P/E (sur 12 mois)	14,77
BPA (sur 12 mois)	10,19
Date de bénéfices	01 févr. 2023 - 06 févr. 2023
Dividende et rendement à terme	2,64 (1,77 %)
Date ex-dividende	17 janv. 2023
Objectif sur 1 an	143,07

Tous

ACCESSWIRE
Empowering Students To Create Better Health Outcomes Through School-Based Journalism
NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Quest Diagnostics Healthy NewsWorks Healthy NewsWorks (HNW) empowers elementary and middle-school students to advocate for health literacy through school-based journalism programs. HNW provides ...
ACCESSWIRE
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that Jim Davis has succeeded Steve Rusckowski as the CEO and President of Quest Diagnostics, completing a transition first announced on February 3, 2022.
ACCESSWIRE
Historically Black Colleges and Universities STEM Students Selected for Health Care Program
According to the Association of American Medical Colleges, only 8% of medical students and 5% of physicians are Black and African American.